Diabetes drug may help symptoms of autism associated condition

May 15, 2017
Metformin 500mg tablets. Credit: public domain

A widely used diabetes medication could help people with a common inherited form of autism, research shows.

Scientists found that a drug called improves sociability and reduces symptomatic behaviours in adult mice with a form of Fragile X syndrome.

Researchers say that metformin could be repurposed as a therapy for Fragile X syndrome within a few years - if clinical trials prove successful.

Fragile X syndrome is caused by inherited defects in a gene called FMR1, which leads to excess in the brain.

This results in the breakdown of connections between brain cells, leading to changes in behaviour.

The team led by the University of Edinburgh and McGill University in Canada looked at the effects of metformin on mice that lack the FMR1 gene.

These mice usually have symptoms consistent with Fragile X syndrome - they exhibit repetitive behaviours such as increased grooming and do not socialise with other mice.

After mice had treatment with metformin for ten days, protein production in the brain returned to typical levels, brain connections were repaired and they displayed normal behaviour patterns, the researchers found.

The therapy also reduced the occurrence of seizures, which are reported to affect between 10 and 20 per cent of people with Fragile X.

Fragile X Syndrome affects around 1 in 4,000 boys and 1 in 6,000 girls. It is the most common known cause of inherited intellectual disability. Affected children have developmental delays that impair speech and language, problems with social interactions and are often co-diagnosed with autism, anxiety and seizures.

Metformin is already approved by the UK's Medicines and Healthcare products Regulatory Agency and the US Food and Drug Administration as a therapy for type 2 diabetes.

Dr. Christos Gkogkas, Chancellor's Fellow at the University of Edinburgh's Patrick Wild Centre, said: "Metformin has been extensively used as a therapy for type 2 diabetes for more than 30 years, and its safety and tolerability are well documented. Our study suggests the drug could be a novel therapeutic for Fragile X syndrome, a common type of autism. We next plan to investigate whether metformin offers any benefits for other types of autism."

Dr. Nahum Sonenberg, James McGill Professor at McGill University's Biochemistry Department, commented: "This is some of the most exciting research work in my career, as it offers great promise in treating a pernicious genetic disease for which there is no cure."

Dr. Andrew Stanfield, Co-director of the Patrick Wild Centre for Research into Autism, Fragile X Syndrome and Intellectual Disabilities, said: "'These findings are particularly important as metformin is a commonly used drug for other conditions so we already know a lot about its safety profile. If in people with Fragile X are successful then it could be in use much more quickly than would be the case for a brand new medication."

The study is published in the journal Nature Medicine.

Explore further: Fragile X study offers hope of new autism treatment

More information: Nature Medicine (2017). DOI: 10.1038/nm.4335

Related Stories

Fragile X study offers hope of new autism treatment

November 27, 2014
People affected by a common inherited form of autism could be helped by a drug that is being tested as a treatment for cancer.

Fragile X study offers new drug hope

September 24, 2012
(Medical Xpress)—An experimental drug can improve sociability in patients with fragile X syndrome and may be helpful as a treatment for autism, according to a study.

Treatment window for Fragile X likely doesn't close after childhood

March 20, 2017
Brain samples from humans show that the treatment window for Fragile X syndrome likely remains open well into maturity after childhood, when previous tests with mice indicated it might close, according to a new Drexel University-led ...

Study shows early brain changes in Fragile X syndrome

January 31, 2017
A new study led by scientists at The Scripps Research Institute (TSRI) is giving researchers a first look at the early stages of brain development in patients with Fragile X syndrome, a disorder that causes mild to severe ...

Intellectual disabilities share disease mechanisms, study suggests

November 10, 2015
Brain disorders that cause intellectual disabilities and autism spectrum disorders may share common defects despite having different genetic causes, a study has found.

Study on fragile X syndrome uses fruitfly's point of view to identify new treatments

April 26, 2016
Fragile X syndrome (FXS) is the most common genetically inherited cause of intellectual disability in humans. New research shows how the hormone insulin—usually associated with diabetes—is involved in the daily activity ...

Recommended for you

Finding a natural defense against clogged arteries

September 20, 2017
In type 2 diabetes, chronic inflammation drives cardiovascular disease, the leading cause of death among people with the condition. Researchers at Joslin Diabetes Center now have identified an unexpected natural protective ...

Study identifies blood vessel as a therapeutic target for diabetes

September 14, 2017
Blood vessels have an often overlooked role of regulating the transfer of nutrients from the blood to organs in the body. In a new Yale-led study, researchers have identified a role of a secreted protein, apelin, in regulating ...

Drug for type 2 diabetes provides significant benefits to type 1 diabetic patients

September 14, 2017
A majority of patients with Type 1 diabetes who were treated with dapagliflozin, a Type 2 diabetes medicine, had a significant decline in their blood sugar levels, according to a new study published in The Lancet Diabetes ...

Epigenetic 'fingerprint' identifies diabetes risk

September 14, 2017
Deakin researchers have identified an epigenetic marker that predicts risk of type 2 diabetes in women with gestational diabetes.

Could swine flu be linked to type 1 diabetes?

September 14, 2017
(HealthDay)—Young people who've been infected with the H1N1 swine flu virus may be at increased risk for type 1 diabetes, a new study suggests.

Time to dial back on diabetes treatment in older patients? Study finds 11 percent are overtreated

September 14, 2017
Anyone with diabetes who takes blood sugar medication knows their doctor prescribed it to help them. After all, the long-term effects of elevated blood sugar can harm everything from the heart and kidneys to the eyes and ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

LaPortaMA
not rated yet May 15, 2017
Quite the coincidence.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.